The pharmaceutical industry's ability to develop and produce effective treatments hinges on the consistent availability of high-quality chemical intermediates. For Empagliflozin, a widely used SGLT-2 inhibitor for type 2 diabetes, its synthesis relies on specific precursor molecules. One such critical component is Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-alpha-D-glucopyranoside, identified by CAS number 1279691-36-9.

As a specialized manufacturer in China, NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing this vital Empagliflozin intermediate with exceptional purity. The precise chemical synthesis of this C24H29ClO8 molecule is key to ensuring the efficacy and safety of the final drug product. Our manufacturing processes are designed to meet the stringent demands of pharmaceutical clients worldwide, offering a reliable source for this important building block.

The importance of sourcing pharmaceutical intermediate CAS 1279691-36-9 cannot be overstated. It forms a crucial part of the molecular structure required for SGLT-2 inhibition, making its quality paramount. By focusing on high-purity chemical synthesis, we enable our clients to achieve optimal yields and quality in their API production. Our commitment as a supplier in China is to support the global pharmaceutical supply chain with essential, well-characterized compounds.

The intricate nature of organic synthesis means that each step must be carefully controlled. Our expertise in producing tetrahydro-3-furanyloxyphenylmethylphenyl alpha-D-glucopyranoside ensures that researchers and manufacturers have access to a dependable starting material for their critical antidiabetic drug development projects. NINGBO INNO PHARMCHEM CO.,LTD. is proud to contribute to advancements in healthcare through our specialized chemical manufacturing capabilities.